McKay D M
Intestinal Disease Research Programme, McMaster University, Hamilton, Canada.
Can J Gastroenterol. 1999 Jul-Aug;13(6):509-16. doi: 10.1155/1999/680206.
The idea that the enteric microflora play a role in the pathogenesis or pathophysiology of inflammatory bowel disease (IBD) is not new. Indeed, identification of an infective cause for chronic IBD, and particularly for Crohn's disease, has been the focus of extensive research efforts. During the 1990s, there has been a noticeable re-emergence of interest in the link between bacteria and functional bowel disorders, and the value of antibiotic therapy to treat gut inflammatory disorders. A variety of experimental evidence from both laboratory model systems and clinical investigations is reviewed with respect to a pivotal role for enteric bacteria in gut inflammation. The voluminous scientific literature on this subject precludes any comprehensive synopsis of the area; instead, pertinent studies are cited to illustrate the ability of bacteria and their products to evoke or exacerbate gut inflammation.
肠道微生物群在炎症性肠病(IBD)的发病机制或病理生理学中发挥作用这一观点并不新鲜。事实上,确定慢性IBD,尤其是克罗恩病的感染病因,一直是广泛研究工作的重点。在20世纪90年代,人们对细菌与功能性肠道疾病之间的联系以及抗生素治疗肠道炎症性疾病的价值重新产生了显著兴趣。本文回顾了来自实验室模型系统和临床研究的各种实验证据,以探讨肠道细菌在肠道炎症中的关键作用。关于这一主题的大量科学文献使得无法对该领域进行全面概述;相反,引用了相关研究来说明细菌及其产物引发或加剧肠道炎症的能力。